- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02195557
Retrospective Follow-up Study of Synvisc® in Patients With Knee Osteoarthritis
July 21, 2014 updated by: Boehringer Ingelheim
Synvisc® in Knee Osteoarthritis: Retrospective Follow-up in Treated Patients Since at Least Three Years
Retrospective collection of data, aimed at a better knowledge of the use of Synvisc® among the patients with knee osteoarthritis (OA) since at least three years.
Study Overview
Study Type
Observational
Enrollment (Actual)
16
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
rheumatological practice
Description
Inclusion Criteria:
- Patients with knee osteoarthritis using Synvisc® since at least three years
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Synvisc®
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reason for prescription
Time Frame: at least 3 years before start of observation period
|
at least 3 years before start of observation period
|
|
Number of other treatments per patient
Time Frame: at least 3 years of observation
|
antalgics, non-steroid anti-inflammatory drugs (NSAIDs), steroid anti-inflammatory drugs (SAIDs), specific symptomatic treatments and surgery
|
at least 3 years of observation
|
Time between two treatments
Time Frame: at least 3 years of observation
|
at least 3 years of observation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2002
Primary Completion (Actual)
March 1, 2003
Study Registration Dates
First Submitted
July 18, 2014
First Submitted That Met QC Criteria
July 18, 2014
First Posted (Estimate)
July 21, 2014
Study Record Updates
Last Update Posted (Estimate)
July 22, 2014
Last Update Submitted That Met QC Criteria
July 21, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1139.6
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis
-
Sanford HealthActive, not recruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder Osteoarthritis | Ankle Osteoarthritis | Wrist OsteoarthritisUnited States
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
University of California, San FranciscoStanford University; Robert Wood Johnson FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
University of VermontCompletedOsteoarthritis of Knee | Osteoarthritis Of HipUnited States
-
University of EdinburghHospital for Special Surgery, New YorkRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited Kingdom
-
Mayo ClinicCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
Sword Health, SAHospital da PreladaCompletedEfficacy of a Digital Biofeedback System for Home-based Rehabilitation After Total Joint ReplacementKnee Osteoarthritis | Hip OsteoarthritisPortugal
-
The Hawkins FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
Massachusetts General HospitalNewton-Wellesley HospitalCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
Clinical Trials on Synvisc®
-
Boehringer IngelheimCompletedOsteoarthritis
-
Boehringer IngelheimCompleted
-
PulsalysArtialisCompletedKnee Osteoarthritis | Intra-Articular InjectionBelgium
-
IBSA Institut Biochimique SACompletedOsteoarthritis, KneeCzech Republic, France, Germany, Italy, Slovakia, Switzerland
-
SanofiCompleted
-
Boehringer IngelheimCompleted
-
University of Sao Paulo General HospitalUnknown
-
Sheltering Arms Physical Rehabilitation HospitalsGenzyme, a Sanofi Company; Virginia Commonwealth UniversityUnknown
-
University of OxfordUnknownKnee OsteoarthritisUnited Kingdom
-
Anthony LukeCompletedOsteoarthritisUnited States